NDC 59572-775

Luspatercept

Luspatercept

Luspatercept is a Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Celgene. The primary component is Luspatercept.

Product ID59572-775_0619a105-2e09-4d73-a492-8f3ad7a61ec3
NDC59572-775
Product TypeHuman Prescription Drug
Proprietary NameLuspatercept
Generic NameLuspatercept
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2019-11-08
Marketing CategoryBLA / BLA
Application NumberBLA761136
Labeler NameCelgene
Substance NameLUSPATERCEPT
Active Ingredient Strength75 mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 59572-775-01

1 VIAL, GLASS in 1 CARTON (59572-775-01) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS
Marketing Start Date2019-11-08
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59572-775-01 [59572077501]

Reblozyl INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryBLA
Application NumberBLA761136
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2019-11-08

Drug Details

Active Ingredients

IngredientStrength
LUSPATERCEPT75 mg/1

NDC Crossover Matching brand name "Luspatercept" or generic name "Luspatercept"

NDCBrand NameGeneric Name
59572-711LuspaterceptLuspatercept
59572-775LuspaterceptLuspatercept

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.